This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

HARRY SOBOTKA, Ph.D.; WALTER MANN, B.S.; EDITH FELDBAU

Arch Derm Syphilol. 1940;42(2):270-276.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

EXCRETION OF ARSENIC

In the course of the study of continuous intravenous drip therapy of early syphilis, we had the opportunity to study the excretion of arsenic in the feces and urine of 35 patients during the period of treatment in the hospital. A few years ago the urinary excretion of arsenic was studied in this laboratory after therapy with massive doses of neoarsphenamine in 24 patients.¹ The patients had received 2.4 to 5 Gm., with an average of 4 Gm., of neoarsphenamine during the treatment, which lasted for four to six days. The amount of arsenic administered varied between 480 and 1,000 mg., of which 77 to 290 mg. was found to be excreted in the urine. The percentage of elimination varied from 11.6 to 37.2 during the treatment period, usually of five days, with an average of 21.1 per cent.

Since a greater fraction of the arsenic . . . [Full Text PDF of this Article]

Author Affiliations
NEW YORK

Footnotes
Read at a Conference on Massive Arsenotherapy in Early Syphilis by the Continuous Intravenous Drip Method at Mount Sinai Hospital, New York, April 12, 1940.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?